ARIDIS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On June 8, 2023, Aridis Pharmaceuticals, Inc. issued a press release announcing financial and corporate results for the first quarter ended March 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

99.1 Press Release of Aridis Pharmaceuticals, Inc. dated June 8, 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

-2-

© Edgar Online, source Glimpses